本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

2.75
+0.07002.61%
盘后2.790.0400+1.45%19:40 EDT
成交量:17.77万
成交额:48.46万
市值:7,970.88万
市盈率:-1.13
高:2.79
开:2.68
低:2.63
收:2.68
数据加载中...
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/29

重要事件披露

8-K - Current report
2022/03/30

重要事件披露

8-K - Current report
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/19

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/07/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933